Langbahn Team – Weltmeisterschaft

Cyclopropylmescaline

Cyclopropylmescaline
Names
Preferred IUPAC name
2-[4-(Cyclopropylmethoxy)-3,5-dimethoxyphenyl]ethan-1-amine
Other names
4-Cyclopropylmethoxy-3,5-methoxy-phenethylamine
4-Cyclopropylmethoxy-3,5-methoxy-1-ethane
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
UNII
  • InChI=1S/C14H21NO3/c1-16-12-7-11(5-6-15)8-13(17-2)14(12)18-9-10-3-4-10/h7-8,10H,3-6,9,15H2,1-2H3 checkY
    Key: LNTBHKZMYJTHTH-UHFFFAOYSA-N checkY
  • InChI=1/C14H21NO3/c1-16-12-7-11(5-6-15)8-13(17-2)14(12)18-9-10-3-4-10/h7-8,10H,3-6,9,15H2,1-2H3
    Key: LNTBHKZMYJTHTH-UHFFFAOYAG
  • COc2cc(cc(OC)c2OCC1CC1)CCN
Properties
C14H21NO3
Molar mass 251.326 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
checkY verify (what is checkY☒N ?)

Cyclopropylmescaline (CPM or 4-cyclopropylmethoxy-3,5-dimethoxyphenethylamine) is a lesser-known psychedelic drug. CPM was first synthesized by Alexander Shulgin. In his book PiHKAL, the dosage range is listed as 60–80 mg and the duration listed as 12–18 hours.[1] CPM produces closed-eye imagery, visuals, and fantasies. It also causes enhancement of music.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of CPM. The drug acts as a serotonin 5-HT2 receptor agonist.[2]

See also

References

  1. ^ a b Shulgin, Alexander; Shulgin, Ann (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628. CPM Entry in PiHKAL
  2. ^ Wallach J, Cao AB, Calkins MM, Heim AJ, Lanham JK, Bonniwell EM, Hennessey JJ, Bock HA, Anderson EI, Sherwood AM, Morris H, de Klein R, Klein AK, Cuccurazzu B, Gamrat J, Fannana T, Zauhar R, Halberstadt AL, McCorvy JD (December 2023). "Identification of 5-HT2A receptor signaling pathways associated with psychedelic potential". Nat Commun. 14 (1): 8221. doi:10.1038/s41467-023-44016-1. PMC 10724237. PMID 38102107.


Bahnsport-Info

Kostenfrei
Ansehen